CBD oil is in high demand around the world for it is natural ingredients and remedial and promising health benefits. This is because people are eager to try alternatives to pharmaceuticals due to unwanted side effects. However, it is understandable to be skeptical. Many people praise CBD with positive anecdotes, but what does the latest research suggest?
Research on CBD
Although the area of vaping CBD in particular has not yet been researched thoroughly, some health claims of oral consumption already appear to be supported by studies. So far, many experts do believe that CBD may be effective in soothing chronic symptoms of anxiety and pain, due to its relieving properties. Alongside this, the therapeutic effects of CBD as seizure and epileptic treatment are currently being explored. As CBD is believed to have antioxidant properties, researchers are keen to investigate the use of CBD for neurodegenerative disease, anxiety disorders, childhood diseases like tuberous sclerosis, and addiction.
Despite current evidence being limited, CBD seems to offer many health benefits and could be adopted worldwide and used as part of treatment plans for many conditions if future findings confirm initial assumptions.
Research on Similar Therapies
Despite the majority of clinical trials for CBD primarily focusing on capsules and sprays, there is extensive research on aerosolized therapies for conditions like asthma and chronic obstructive pulmonary disease. The delivery of this therapy has shown to produce rapid results with a lower dosage supplied directly into the lungs. The efficiency of condensation aerosols could potentially set an example for the possibilities of vaping which is great for suppliers like nectarmedicalvapes.com — but further research is vital in establishing this.
Approved CBD Medicines
However, so far the Food and Drug Administration have only approved the use of the CBD-based mouth spray Epidiolex for use in treating two forms of epilepsy — Lennox-Gastaut or Dravet syndrome. In Canada and Europe, the CBD and THC-infused mouth spray Sativex is approved for doctors to prescribe to treat patients with multiple sclerosis. This could be indicative of progress to come in the future following further developments in research. 228 studies on CBD have either been completed, are active, or are pending results (according to the US National Library of Medicine) which could contain groundbreaking evidence of the health benefits claimed by many.
To summarize, confirmation of the current claims of health benefits from CBD usage demands further research. Despite this, current studies are hopeful and indicate that CBD could be effective in soothing anxiety and pain, as well as symptoms of epilepsy, addiction, and multiple sclerosis to name a few — with mouth sprays approved for prescription across the US, Canada, and Europe. Many studies are focused on capsules and sprays, but the success of aerosolized therapies for asthma and chronic obstructive pulmonary disorder may foreshadow the future usage of CBD for treatment plans across the world. Ultimately, natural remedies are worth trying (with the assistance of a medical professional) to form a personal opinion on its effects until the science is developed.
